Establishing Reliable Biomarkers of Aging
for Longevity Interventions
Building consensus and standards through collaboration and open science
Our Call To Action
Gaps in Standardization and Harmonization
The lack of standardized, clinically validated methods to accurately measure aging as well as the safety and efficacy of interventions creates a bottleneck in translating those interventions into viable therapeutics.
Lack of Biomarkers of Aging
There is an unmet need to establish consensus and standards for biomarkers of aging, in order to advance scientific understanding and ensuring the success of innovations and interventions worldwide.
October 20-21, 2025
The Joseph B. Martin Conference Center at Harvard Medical School
2025 Biomarkers of Aging Conference
Join world-renown academic and industry leaders defining the future of aging biomarkers
Our Programs
We achieve our mission through open science, global collaboration, and sharing of critical data, tools, and insights.
-
Our 2-day, in-person Conference at the Joseph B. Martin Conference Center at Harvard Medical School in Boston, featuring cutting-edge academic science of biomarkers of aging as well as translational, clinical and regulatory aspects of biomarkers of aging featuring the world’s leading academic and industry scientists.
Learn more. -
We bring together leading researchers and stakeholders in the geroscience field to build and publish consensus roadmaps and standards for the systematic development and validation of biomarkers of aging.
-
A first-of-its-kind, open source library designed for the evaluation and unified validation of biomarkers of aging, and contains many curated and harmonized large, high-quality omics and health datasets.
Learn more. -
Our Biomarkers of Aging Challenge stimulates innovation and collaboration in the development of next-generation biomarkers that are highly predictive of chronological age, mortality, and multi-morbidity.
-
A longitudinal multi-modal deep-profiling study leverages community-based cohorts and state-of-the-art molecular and functional profiling to explore how aging affects us at molecular and functional levels, shedding light on the changes driving functional decline.
From scholars and healthcare practitioners to longevity industry pioneers and regulatory leaders, together we are advancing the development, validation, and implementation of aging biomarkers through cutting-edge translational research
A global, collaborative geroscience community
Partners & Collaborators
Join Us
If you are interested in joining or supporting the Consortium, please tell us a bit about yourself.